# Novelo — UI/UX Pro Max Integration & Design System Research Report

**Document Version:** 1.0.0  
**Date:** 2026-11-05  
**Project:** Novelo — *Medication, made manageable.*  
**Package:** `com.example.nuvilo`  
**Platform:** Native Android, Kotlin 2.2, Jetpack Compose, Material 3  
**Target Design Skill:** UI/UX Pro Max v2.15.0  
**Target Repository:** `https://github.com/nextlevelbuilder/ui-ux-pro-max-skill`  
**Inspected Upstream Commit:** `b7d5353e0130feb8c5574ef1251f8a1db1873ccb`  
**Stage:** Stage 1 of 2 (Skill Installation, Master Design System Generation & Research)

---

## 1. Executive Summary

This report completes **Stage 1** of Novelo's UI/UX improvement initiative. The official **UI/UX Pro Max** design intelligence skill (v2.15.0) was inspected, installed project-locally for Antigravity, and executed against Novelo's product specifications.

Using the local Python-based search engine and design-system synthesizer, we generated:
1. **Master Design System Specification**: `design-system/novelo/MASTER.md` (Category: *Medication & Pill Reminder*, Variance 5/10, Motion 3/10, Density 4/10).
2. **Seven Domain-Specific Research Artifacts**: Saved in `docs/ui-ux-audit/pro-max-research/` covering typography, mobile data presentation, colour palettes, visual styles, data visualization, and native Jetpack Compose implementation.
3. **Comparative Analysis & Synthesis**: Aligning UI/UX Pro Max recommendations with Novelo's existing clinical blue brand (`#005EB8`), WCAG AA contrast rules, and strict offline privacy constraints.

**Implementation Boundary:** In strict accordance with Stage 1 guidelines, zero production Kotlin UI files, Gradle dependencies, or theme definitions were altered. Application screens remain unchanged pending Stage 2.

---

## 2. Environment, CLI & Installation Verification

### 2.1 Toolchain Verification
| Tool / Runtime | Required | Inspected Version | Status |
| :--- | :--- | :--- | :--- |
| **Node.js** | `>= 18.0.0` | `v24.21.0` | Verified |
| **npm** | `>= 9.0.0` | `11.19.0` | Verified |
| **Python 3** | `>= 3.10.0` | `3.11.3` (`C:\Users\ddona\AppData\Local\Programs\Python\Python311\python.exe`) | Verified |
| **`uipro` CLI** | `2.15.0` | `2.15.0` (`ui-ux-pro-max-cli@2.15.0`) | Verified |

### 2.2 Skill Installation
The skill was initialized using the official Antigravity integration command:
```powershell
uipro init --ai antigravity
```
- **Local Directory:** `.agents/skills/ui-ux-pro-max/`
- **Skill Entry Point:** `.agents/skills/ui-ux-pro-max/SKILL.md`
- **Search Script:** `.agents/skills/ui-ux-pro-max/scripts/search.py`
- **Data Catalogues:** 18 CSV/JSON datasets installed in `.agents/skills/ui-ux-pro-max/data/` (including `products.csv`, `styles.csv`, `colors.csv`, `typography.csv`, `charts.csv`, `ux-guidelines.csv`, and `stacks/jetpack-compose.csv`).

> [!NOTE]
> Antigravity automatically detects newly installed skills in `.agents/skills/` across conversation sessions. For the current session, the skill scripts and instructions were executed and read directly.

---

## 3. Upstream Licensing Audit & Commercial Safeguards

A critical review of the upstream repository revealed a licensing discrepancy:
- **Root Repository `LICENSE` File:** Declares the permissive **MIT License** (Copyright © 2024 Next Level Builder).
- **`skill.json` & npm Registry Metadata:** Lists `"license": "MIT"`.
- **`README.md` (Root & npm package):** Concludes with a conflicting `## License \n CC-BY-NC-4.0` statement.

### Commercial Safeguards for Novelo:
Because Novelo is designed as a commercially viable, store-ready native Android product:
1. **Zero Upstream Bundling:** Upstream skill scripts, templates, and CSV datasets are developer-only intelligence assets. They must **never** be packaged into the Android APK or bundled into application assets.
2. **Git Commit Boundary:** Upstream skill files in `.agents/skills/ui-ux-pro-max/` are excluded from version control commits to avoid any copyright or licensing ambiguity.
3. **Original Deliverables:** All design system documents (`design-system/novelo/MASTER.md`), research summaries, and subsequent Compose component implementations are original project deliverables.

---

## 4. Master Design System Synthesis (`design-system/novelo/MASTER.md`)

The design system generator was executed with Novelo's product parameters:
```powershell
python .agents/skills/ui-ux-pro-max/scripts/search.py "premium medication reminder and management healthcare companion mobile application" --design-system --persist --variance 5 --motion 3 --density 4 -p "Novelo" --output-dir "." -f markdown
```

### 4.1 Core Profile & Dial Decisions
- **Selected Product Archetype:** `Medication & Pill Reminder` (Catalog ID 145).
- **Pattern:** `Trust & Authority + Conversion` — Prioritizes medical credibility, clinical transparency, and frictionless dose actions.
- **Style:** `Accessible & Ethical` + `Material 3 Expressive (Mobile)` — High contrast, generous touch targets ($\ge 48\text{dp}$), clear focus states, and zero color-only status communication.
- **Variance Dial (5/10 — Balanced / Modern):** Distinctive editorial layout without eccentric brutalism or sterile generic minimalism.
- **Motion Dial (3/10 — Subtle):** Purposeful, fast-out-slow-in micro-transitions (150–250ms) that provide immediate tactile confirmation without slowing the user down.
- **Density Dial (4/10 — Standard):** Comfortable spacing grid (8dp–24dp) ensuring effortless readability for users with varied visual acuity.

### 4.2 Spacing & Dimension Tokens
| Token | Dimension | Jetpack Compose Equivalent | Usage |
| :--- | :--- | :--- | :--- |
| `--space-xs` | `4px` | `4.dp` | Inline icon-to-text spacing, tight chip padding |
| `--space-sm` | `8px` | `8.dp` | Gaps between related controls, chip row spacing |
| `--space-md` | `16px` | `16.dp` | Screen edge padding, standard card content padding |
| `--space-lg` | `24px` | `24.dp` | Section vertical spacing, hero card internal padding |
| `--space-xl` | `32px` | `32.dp` | Screen section margins, dialog padding |
| `--space-2xl` | `48px` | `48.dp` | Minimum touch target bounding box (`minimumInteractiveComponentSize`) |
| `--space-3xl` | `64px` | `64.dp` | Bottom navigation bar clearing space |

---

## 5. Domain Research & Key Findings

### 5.1 Typography Research (`typography-research.md`)
- **Query:** `"accessible premium typography hierarchy medication names dosage numerical data healthcare mobile interface" --domain typography -n 12 --full`
- **Key Findings:**
  1. *Medical Clean Pairing (Figtree + Noto Sans)*: Recommended for high clinical clarity, distinct numeral shapes, and strong weights (400 to 700).
  2. *Bold Typography Mobile (Inter 600–800 + JetBrains Mono)*: Recommends letter spacing of `-0.5sp` on headlines and tabular numerals (`FontFeatureSettings = "tnum"`) for timestamps, dosage numbers, and stock quantities.
  3. *Offline Native Constraint*: Remote Google Fonts downloads are forbidden by Novelo's offline architecture. Android's native `FontFamily.SansSerif` (Roboto) provides complete font weights, system font scaling (Dynamic Type / Sp), and built-in tabular numeral support.

### 5.2 Mobile Data Presentation & Tables (`mobile-data-presentation.md`)
- **Query:** `"mobile dense data tables compact readable rows numeric alignment column hierarchy truncation accessibility" --domain ux -n 12 --full`
- **Key Findings:**
  1. *Desktop Table Rejection*: Multi-column spreadsheet tables break on mobile viewports. On phones, dense structured data (Stock Ledger, Dose History, Prescription Audit) must be rendered as **compact structured cards or grouped list rows**.
  2. *Three-Tier Row Architecture*:
     - **Primary Tier (Top Left)**: Bold medication name or event type (14–16sp SemiBold).
     - **Secondary Tier (Bottom Left)**: Muted supporting context (timestamp, reason, batch number) in Slate 500 (12sp Normal).
     - **Numeric Tier (Top/Bottom Right)**: Right-aligned quantitative metric (quantity delta, days runway, percentage) in bold tabular font.
  3. *Pill & Chip Overflow*: Pills and badges must declare `maxLines = 1` with ellipsis or dynamic shrinkage (`nowrap` equivalent). Interactive chips must expose their state (`checked`/`selected`) to TalkBack semantics.

### 5.3 Colour & Visual Identity (`colour-research.md` & `visual-style-research.md`)
- **Queries:**
  - Colour: `"premium healthcare mobile application trusted blue brand neutral surfaces accessible light dark semantic status palette" --domain color -n 12 --full`
  - Style: `"premium personal healthcare medication companion mobile interface sophisticated calm distinctive design" --domain style -n 10 --full`
- **Key Findings:**
  1. *Brand Blue Assessment*: UI/UX Pro Max generated `#0284C7` (Sky Medical Blue) and `#0891B2` (Clinical Cyan). Novelo's established NHS-inspired blue (`#005EB8`) carries strong clinical trust and must be **retained** as the primary brand anchor. However, `#0284C7` and `#0891B2` serve as excellent secondary accents, tonal progress ring colors, and active filter highlights.
  2. *Dark Theme Foundation*: Pro Max emphasizes Slate-navy surfaces (`#0F172A`, `#1E293B`) over harsh pure black (`#000000`). Novelo's existing `#0B111A` (root canvas) and `#131C27` (card surface) align with these principles, ensuring $8:1+$ contrast while preventing OLED smear and eye strain.
  3. *Material 3 Expressive (Mobile)*: Recommends pill-shaped chips (`RoundedCornerShape(999.dp)`), tonal elevation over heavy drop shadows, and standard haptic feedback on confirmations.

### 5.4 Chart & Adherence Visualizations (`chart-research.md`)
- **Query:** `"accessible mobile medication adherence trend charts monthly history compact healthcare analytics" --domain chart -n 10 --full`
- **Key Findings:**
  1. *Bullet Charts & Target KPI Cards*: Space-constrained mobile screens should prefer bullet-style KPI meters over oversized radial gauges. Novelo's adherence screen should prominently feature a 30-day KPI card displaying actual adherence against the 80% clinical benchmark.
  2. *Geometric Symbolism*: Time-series charts and calendar grids must never differentiate dose outcomes by color alone. Every taken (`✓`), assumed (`~`), skipped (`×`), and missed (`!`) indicator must pair its color with an unambiguous geometric icon and text label.

### 5.5 Jetpack Compose Stack Guidelines (`jetpack-compose-research.md`)
- **Query:** `"premium Material 3 native Android interfaces accessible typography responsive layouts information hierarchy component states motion" --stack jetpack-compose -n 12 --full`
- **Key Findings:**
  1. *Theming Tokens*: Strictly consume `MaterialTheme.colorScheme`, `MaterialTheme.typography`, and `MaterialTheme.noveloColors`. Never hardcode raw hex values or raw `sp` in composable bodies.
  2. *Accessibility Semantics*: Interactive touch targets must meet the minimum 48x48dp bounds (`minimumInteractiveComponentSize`). Icons must declare clear `contentDescription` or `null` for purely decorative assets.
  3. *Layout Performance*: Flatten nested layout hierarchies (avoid `Box { Column { Box { Row { ... } } } }`). Chain modifiers directly (`Modifier.padding().fillMaxWidth()`).
  4. *List Virtualization*: Always prefer `LazyColumn` with stable keys (`key = { it.id }`) and content types (`contentType = { ... }`) for dose occurrences and ledger movements.

---

## 6. Comparative Synthesis: Current Novelo vs. UI/UX Pro Max

| Design Area | Current Novelo Implementation | UI/UX Pro Max Finding | Stage 2 Proposed Direction |
| :--- | :--- | :--- | :--- |
| **Brand Primary Blue** | `#005EB8` (Deep NHS-inspired clinical blue) | `#0284C7` (Sky medical blue) | **Preserve `#005EB8`** as brand anchor; adopt `#0284C7` as secondary accent and container highlight. |
| **Dark Theme** | `#0B111A` (canvas), `#131C27` (card surface) | `#0F172A` / `#1E293B` Slate Navy | **Preserve & refine**: Keep Novelo's calm slate palette; apply M3 tonal elevation overlays. |
| **Typography Scale** | 15-style Material 3 scale on System Sans | Figtree + Noto Sans pairing | **Refine System Sans with tabular numerals (`tnum`)** for dose quantities, timestamps, and stock numbers. |
| **Corner Radii** | `8.dp` (badges), `12.dp` (buttons), `16.dp` (cards) | Pill-shaped (`999.dp`) for chips/buttons, `12–24.dp` for containers | **Adopt full pill radius (`999.dp`)** for compact status badges, dosage form chips, and primary action buttons. |
| **Dense Data Presentation** | Mixed card lists and collapsible rows | Structured 3-tier compact rows; right-aligned tabular numerals | **Adopt 3-tier row structure** for Dose History, Stock Ledger, and Prescription Timeline. |
| **Adherence Visualizations** | Monthly dot calendar + percentage bar | Bullet chart KPI with target threshold benchmarks | **Adopt Bullet KPI pattern** on Adherence screen: actual adherence bar with clinical 80% target marker. |
| **Motion & Micro-Interactions** | Fast-out-slow-in spring curves (`NoveloMotion`) | Dial 3: 150–250ms subtle fade + 8–12px slide | **Preserve `NoveloMotion`**; align modal entrance/exit transitions with standard 200ms easing. |
| **Status Indication** | 5 semantic states with icon + text + background | Prohibits color-only status; requires $\ge 4.5:1$ contrast | **Retain**: Novelo's `noveloColors` system already guarantees $\ge 5.2:1$ contrast in both modes. |

---

## 7. Recommendations NOT to Adopt (With Technical Justifications)

1. **Do NOT adopt GSAP, CSS, or Web JavaScript code**: The generator provided web GSAP animation snippets (`gsap.from(...)`). Novelo is native Android Compose; these concepts must be implemented purely using Compose `Animatable`, `AnimatedVisibility`, or `NoveloMotion`.
2. **Do NOT download or load Google Fonts at runtime**: Violates Novelo's zero-network offline boundary (`android.permission.INTERNET` forbidden).
3. **Do NOT replace `#005EB8` with `#0284C7`**: Novelo's deep blue has established brand recognition and authoritative clinical trust; replacing it would make the application look like a generic SaaS tool.
4. **Do NOT use horizontal-scrolling desktop tables**: Multi-column data grids degrade mobile usability and accessibility.

---

## 8. Actionable Roadmap for Stage 2 Implementation

When Stage 2 is initiated, component and screen enhancements should proceed in the following ordered sequence:

1. **Tokens & Theme Foundation (`ui/theme/`)**:
   - Update `Shape.kt`: Add `Pill = RoundedCornerShape(999.dp)` for badges, filter chips, and primary buttons.
   - Update `Type.kt`: Configure tabular numerals (`FontFeatureSettings = "tnum"`) for timestamps, quantities, and balances.
   - Refine `Color.kt`: Harmonize secondary and tonal container tokens (`#E1EFFF`, `#DDF5F4`).
2. **Shared Design System Components (`ui/components/`)**:
   - Update `StockBadge`, `DoseStatusBadge`, and filter chips to use the M3 Expressive pill silhouette.
   - Refine `HeroDoseCard`: Optimize typography hierarchy and supply runway micro-banner.
   - Refine `TimelineDoseItem` and `MedicationItemCard`: Implement the 3-tier data row pattern.
3. **Screen-by-Screen Polishing**:
   - **Today / Dashboard Screen**: Ensure seamless hero-to-completed transition and compact timeline scanning.
   - **Medications Directory Screen**: Clean filter chip row, prominent `+ Stock` 1-tap action, and pending GP order banner.
   - **Medication Detail Screen**: Refine Hero Stock runway card, collapsible FEFO lot drawer, and prescription repeat actions.
   - **Adherence & History Screen**: Implement the bullet KPI target benchmark card and compact dose correction rows.
   - **Settings Screen**: Clean grouped card surfaces and diagnostic indicator pills.

---

## 9. Deliverables & Git Evidence

- **Master Design System**: `design-system/novelo/MASTER.md`
- **Research Outputs**:
  - `docs/ui-ux-audit/pro-max-research/design-system-generation.md`
  - `docs/ui-ux-audit/pro-max-research/typography-research.md`
  - `docs/ui-ux-audit/pro-max-research/mobile-data-presentation.md`
  - `docs/ui-ux-audit/pro-max-research/colour-research.md`
  - `docs/ui-ux-audit/pro-max-research/visual-style-research.md`
  - `docs/ui-ux-audit/pro-max-research/chart-research.md`
  - `docs/ui-ux-audit/pro-max-research/jetpack-compose-research.md`
- **Comprehensive Report**: `docs/ui-ux-audit/PRO_MAX_RESEARCH.md`
- **Skills Inventory**: `SKILLS_INVENTORY.md` updated with UI/UX Pro Max entry and licensing disclosure.
